Автор туралы ақпарат

Krivorotko, P. V.

Шығарылым	Бөлім	Атауы	Файл
Том 30, № 6/7 (2023)	Clinical experience	Treatment of locally advanced (T2-3N0-1M0) and early (T1-2N0M0) HER2-positive breast cancer (clinical experience)
Том 30, № 6/7 (2023)	Original articles	Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Том 30, № 6/7 (2023)	Original articles	Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer
Том 30, № 11 (2023)	Pharmacological properties of drugs	Trastuzumab deruxtecan in the treatment of breast cancer
Том 30, № 14 (2023)	Oncology	The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Том 32, № 3 (2025)	Reviews	Prognostic value of low HER2 expression in patients with early breast cancer